Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Bad news for actuaries: according to the latest from the US Journal of the American Medical Association, mortality rates for… Read More
Tags: Drug Test, Life Insurance, Mortality, Underwriting
Dr. Steven J. Rigatti, consulting medical director to CRL, discusses the novel use of the CRISPR technique and its potential… Read More
Tags: CRISPR, Crispr Cas9, Dna, Life Insurance, Sickle Cell
Dr. Michael Fulks is a Medical Director for Clinical Reference Laboratory (CRL). He is an expert commentator on core issues… Read More
Tags: Alzheimers, Cardiovascular Disease, Dementia, Life Insurance, Underwriting
Epigenetic testing is a critical part of CRL’s approach to innovative science. Read below to learn about how epigenetic testing… Read More
Tags: Clinical Research, Epigenetics, Insurance, Laboratory, Life Insurance
Is legalized cannabis the answer to America’s opioid crisis? This provocative question is garnering significant attention from the team at Clinical… Read More
Tags: Drugs, Insurance, Life Insurance, Marijuana Legalization, Opiods
From DNA to insuretech to product development, the world of life insurance is moving and will continue to do so… Read More
Tags: Dna, Insurtech, Life Insurance, Risk Management